J Tan88
Set a live reminder
Trader’s Talk is back!
What an exciting past week it has been! Former President Donald Trump is to become the next occupier of the Oval Office once more, becoming the first ever US President to serve 2 non-consecutive terms.
While markets had already priced in a Trump victory even before the votes were tallied, it was the manner of his victory that surprised everyone. Trump secured 312 electoral votes to Kamala Harris’ 226...
What an exciting past week it has been! Former President Donald Trump is to become the next occupier of the Oval Office once more, becoming the first ever US President to serve 2 non-consecutive terms.
While markets had already priced in a Trump victory even before the votes were tallied, it was the manner of his victory that surprised everyone. Trump secured 312 electoral votes to Kamala Harris’ 226...
[Trader’s Talk] Trump 2.0 - What's the impact on US Market?
Nov 11 21:00
27
J Tan88
liked
Dear friends, I just want to share some lessons that I have learnt in the past few months.
I started to accumulate the 3 Mapletree REITs from April till July. Thankfully I bought in at a time when the prices were low. When the Fed cut interest rate by 50 basis points in September, the prices of the reits shot up. At the highest point, my unrealised profit was $40k.
In Oct, the prices started to come down. My mindset at that time was to hold on, afterall I was getting $3k plus ...
I started to accumulate the 3 Mapletree REITs from April till July. Thankfully I bought in at a time when the prices were low. When the Fed cut interest rate by 50 basis points in September, the prices of the reits shot up. At the highest point, my unrealised profit was $40k.
In Oct, the prices started to come down. My mindset at that time was to hold on, afterall I was getting $3k plus ...
23
14
J Tan88
liked
$Mapletree Log Tr (M44U.SG)$ $CapLand IntCom T (C38U.SG)$ Just look at all the REITS ! lol ! Drop fast. When go back up, take forever ! Dont’t waste investors time lah !
13
2
J Tan88
voted
Hi, mooers!
In recent weeks, $Trump Media & Technology (DJT.US)$ has been lifted by specific events, such as Tesla Chief Executive Elon Musk's appearance alongside Donald Trump at campaign rallies. Its stock has climbed 289.79% since its September 24 low and jumped 21.59% on October 28 alone. (Data as of October 29, 2024) Read More>>
So far, many mooers are enjoying returns from $Trump Media & Technology (DJT.US)$ on moomoo! Let’s thr...
In recent weeks, $Trump Media & Technology (DJT.US)$ has been lifted by specific events, such as Tesla Chief Executive Elon Musk's appearance alongside Donald Trump at campaign rallies. Its stock has climbed 289.79% since its September 24 low and jumped 21.59% on October 28 alone. (Data as of October 29, 2024) Read More>>
So far, many mooers are enjoying returns from $Trump Media & Technology (DJT.US)$ on moomoo! Let’s thr...
26
4
J Tan88
voted
$NVIDIA (NVDA.US)$ ended the week with its shares at $141, boosting its market value to $3.47 trillion, making it the world's second-largest company after $Apple (AAPL.US)$. $Microsoft (MSFT.US)$ follows with a market cap of $3.18 trillion as of last Friday. These tech giants are all poised for the next major milestone in market cap, and investors are likely seeing discussions about which companies could reach $4 trillion.
Apple's Advancements
Appl...
Apple's Advancements
Appl...
33
16
J Tan88
liked and commented on
$Gritstone Bio (GRTS.US)$ Reuters· just
Gritstone bio Announces Interim Phase 2 Data for Granite Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer! Well tolerated with no advers events
Gritstone bio Announces Interim Phase 2 Data for Granite Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer! Well tolerated with no advers events
2
6
J Tan88
liked
$Gritstone Bio (GRTS.US)$
Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
Gritstone bio announced encouraging interim Phase 2 data for GRANITE, its individualized neoantigen targeting immunotherapy, in frontline microsatellite stable colorectal cancer (MSS-CRC).
The study showed a 21% relative risk reduction of progression or death with GRANITE vs. control in all treated...
Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
Gritstone bio announced encouraging interim Phase 2 data for GRANITE, its individualized neoantigen targeting immunotherapy, in frontline microsatellite stable colorectal cancer (MSS-CRC).
The study showed a 21% relative risk reduction of progression or death with GRANITE vs. control in all treated...
1